Aortic Valve, Calcification of clinical trials
The registry lists 44 studies for Aortic Valve, Calcification of across more than 10 countries. 15 are recruiting or about to start. 18 of them are mainly about Aortic Valve, Calcification of (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-16.
Get an email when these change. Save the Aortic Valve, Calcification of studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Anteris Technologies Ltd. (4) · Cardiawave SA (3) · Boston Scientific Corporation (3) · National and Kapodistrian University of Athens (2) · Instituto Nacional de Cardiologia Ignacio Chavez (2) · Institut für Pharmakologie und Präventive Medizin (2) · Beijing Anzhen Hospital (2) · Wuhan Union Hospital, China (2)
What is being tested here
Drugs under test in Aortic Valve, Calcification of studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Pioglitazone | 1 | 0 | 1 |
| Folic Acid | 1 | 0 | 1 |
| Ezetimibe | 1 | 1 | 1 |
| Colchicine | 0 | 1 | 1 |
| Denosumab | 0 | 0 | 1 |
| Alendronate | 0 | 0 | 1 |
| Eplerenone | 0 | 0 | 1 |
| Vitamin K 2 | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 5, phase 3 first
- Dec 2026Colchicine and Inflammation in Aortic Stenosis · Phase 3 · Radboud University Medical Center
- Dec 2026Valvular Assessment of New Generation Aortic Replacement Devices · Instituto Dante Pazzanese de Cardiologia
- Dec 2026Derivation and Validation of the Aortic Valve Echocardiographic Calcium Score to Confirm Severe Aortic Stenosis: the Echo-AVCS Study · Azienda Ospedaliera "Sant'Andrea"
- Jun 2027Identification of Genetic Causes of Calcific Aortic Valve Disease · Beth Israel Deaconess Medical Center
- Jun 2027Valvosoft Outcomes Registry for Real-World Evidence · Cardiawave SA
Who these studies take
Of the 8 Aortic Valve, Calcification of studies recruiting now, 6 (75%) set no upper age limit and 1 (13%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 6 (75%) | 6 (75%) |
| 30 | 6 (75%) | 6 (75%) |
| 40 | 6 (75%) | 6 (75%) |
| 50 | 6 (75%) | 6 (75%) |
| 65 | 8 (100%) | 8 (100%) |
| 75 | 7 (88%) | 7 (88%) |
| 85 | 7 (88%) | 7 (88%) |
Across all 44 studies, recruiting or not: 5% stop at 75 or younger and 5% at 65; 18% take children; 0% are for women only and 0% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 44 of 44. search them.
- Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe ARNot yet recruitingNCT07751965Not applicable
- A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV SystemRecruitingNCT07194265Not applicable1 country
- Mechanisms Of Disease Progression in Aortic Stenosis - the MODAS StudyRecruitingNCT058512091 country
- Derivation and Validation of the Aortic Valve Echocardiographic Calcium Score to Confirm Severe Aortic Stenosis: the Echo-AVCS StudyRecruitingNCT076209251 country
- Valvosoft Outcomes Registry for Real-World EvidenceNot yet recruitingNCT075205913 countries
- PCSK9 Inhibitors in the Treatment of Calcific Aortic StenosisNot yet recruitingNCT07256197Phase 31 country
- PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVRRecruitingNCT04889872Not applicable6 countries
- Valvular Assessment of New Generation Aortic Replacement DevicesRecruitingNCT06688448Not applicable1 country
- Effect of PCSK9 Inhibitors on Calcific Aortic Valve StenosisRecruitingNCT04968509Phase 31 country
- ID as a Promoter of IH-induced CAVDNot yet recruitingNCT06200870
- Role of Aortic Valve Composition in Pathophysiology and Diagnosis of Aortic StenosisRecruitingNCT061366891 country
- Deploying Novel Imaging Modalities Towards a Three-dimensional (3D) CARDIOvascular PATHologyNot yet recruitingNCT05975567
- Effects of Pioglitazone in Calcific Aortic Valve DiseaseNot yet recruitingNCT05875675Phase 2
- Folic Acid Supplementation in Calcific Aortic Valve DiseaseNot yet recruitingNCT05861648Phase 2
- Serum and Cellular Biomarkers for Aortic Valve StenosisRecruitingNCT043121391 country
- DurAVR™ THV EU-EFSActive, not recruitingNCT06510855Not applicable1 country
- Colchicine and Inflammation in Aortic StenosisActive, not recruitingNCT05162742Phase 31 country
- DurAVR™ THV System: EMBARK StudyActive, not recruitingNCT05182307Not applicable1 country
- Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility StudyActive, not recruitingNCT05712161Not applicable1 country
- Identification of Genetic Causes of Calcific Aortic Valve DiseaseActive, not recruitingNCT041496001 country
- ACURATE neo2™ Post Market Clinical Follow up StudyActive, not recruitingNCT046552488 countries
- ACURATE Enhance Post Market StudyWithdrawnNCT06959862
- VALVOSOFT® Pivotal StudyCompletedNCT05235568Not applicable3 countries
- Clinical Investigation for the Foldax Tria Aortic Heart Valve- IndiaActive, not recruitingNCT06192706Not applicable1 country
- Prospective Arm of Conduct - Edwards SAPIEN3 PPI RegistryCompletedNCT037158943 countries
- Prognostic Value of Myocardial Fibrosis in Severe Aortic Valve StenosisStatus unknownNCT035859332 countries
- Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.CompletedNCT02132026Phase 21 country
- A Prospective RegistrY of Cardiac Echographic LoopsCompletedNCT033715241 country
- SLOW-Slower Progress of caLcificatiOn With Vitamin K2Status unknownNCT04429035Not applicable1 country
- Analysis and Comparative Evaluation of Aortic Calcium by Computed Tomography and Histopathology in Patients With Aortic StenosisCompletedNCT043443531 country
- Evaluation of the Inflammatory Response in Post-operated Aortic Valve Replacement Patients.CompletedNCT045573451 country
- Edwards SAPIEN 3 PPI RegistryCompletedNCT034976111 country
- Accuracy of Using 2D Transesophageal Echocardiography Compared to Balloon Sizing in Determining Valve Size During Transcatheter Aortic Valve ImplantationStatus unknownNCT042422251 country
- Pressure Assessment to Improve Outcomes After TAVR: a RegistryCompletedNCT03923530Early Phase 11 country
- Left Ventricular Reverse Remodeling In Aortic Valve Replacement With Single Strip Pericardium Versus Mechanical ValveStatus unknownNCT04056832Not applicable1 country
- Effective Management of Calcific Aortic Stenosis in the ElderlyCompletedNCT03343314
- The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII BCompletedNCT02184442Not applicable1 country
- Feasibility of Continuous Noninvasive Finger Arterial Blood Pressure Measurement for Detection and Staging of Aortic StenosisStatus unknownNCT030887871 country
- REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve SystEmCompletedNCT01383720Not applicable1 country
- Prevalence and Significance of Mutations in Genes Encoding NaPi-co-transporters in the Development of CAVDStatus unknownNCT025168001 country
- Vitamin K Supplement for Inhibition of the Progress in Aortic Valve CalcificationCompletedNCT00785109Phase 31 country
- Safety and Performance of TAVI of Venus MedTech Aortic Valve ProsthesisStatus unknownNCT01683474Not applicable1 country
- Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVIStatus unknownNCT02221921Not applicable1 country
- Comparison of Aortic Root Dimension Changes During Cardiac Cycle Between the Patients With and Without Aortic Valve Calcification Using ECG-gated 64-slice and Dual-source 256-slice Computed Tomography Scanners: Results of a Multicenter StudyCompletedNCT017558061 country